rongsheng biotech supplier

US Customs records for Xian Rongsheng Biotechnology Co., L, a supplier based in China. See their past imports and exports, including shipments to International Future Technologies in Bradenton, Florida.

Xian Rongsheng Biotechnology Co., Ltd. is one of the renowned Exporter making Food & Beverages and many more China Alpha-arbutin, hyaluronic acid, Astaxanthin, lycopene, coenzyme Q10 products. The manufactory of Xian Rongsheng Biotechnology Co., Ltd. is located in Rm. 3-1917, I Duhui, No. 11, Tangyan South Rd Chengdu Sichuan *** China. Xian Rongsheng Biotechnology Co., Ltd. is a well-known organization in China that is operating transnationally. Xian Rongsheng Biotechnology Co., Ltd. Particulars Name: Mr. Jack Liu

XI’AN RONGSHENG BIOTECHNOLOGY CO., LTD. is specialized in the study, production and sales of natural plant extracts, which was used in the industry of pharmaceutical, dietary supplement, food and cosmetic.

At Rongsheng, we are always committed to giving our customers the excellent products and services that they expect and deserve. The satisfaction of customers is our long-term desire. We will make full use of our own advantages, be aggressive and innovative. We will also actively promote the development of human health industry with the vision of globalization.

1kg Rongsheng Pure Natural Organic Glycyrrhizic Acid Licorice Plant Licorice Root Extract with double plastic container inside/Aluminum foil bag outside. 25kg with double plastic container inside/Fiber drum outside.Or it"s your option.

SHANGHAI, Oct 30 (Reuters) - China Rongsheng, the country’s largest private shipbuilder, has secured a cash lifeline that could be worth up to HK$3.23 billion dollars and is looking to change its name to reflect its shift into oil exploration.

Shares in heavily indebted Rongsheng, which were suspended on Aug. 29 after the company said it was in the process of restructuring, surged almost 17 percent higher after trading resumed on Thursday. They reversed gains, and were down 3.7 pct by 0217 GMT.

Rongsheng said late on Wednesday it would issue warrants worth HK$510 million to a Cayman Islands-incorporated investment firm wholly owned by private equity investor Wang Ping, which would entitle subscribers to buy up to 1.7 billion new shares at HK$1.60 each.

This would raise about HK$3.23 billion for Rongsheng, it said. A warrant entitles the holder to buy stock from the issuer at a specific price within a time frame.

The price of the new shares is at a 17.65 percent premium to Rongsheng’s closing price of HK$1.36 per share on Aug. 28, when it last previously traded. It said the subscription shares represent 19.36 percent of the firm’s issued share capital.

Rongsheng, which builds Brazilian miner’s Vale mega-iron ore carriers, came close to insolvency last year before clinching an agreement with banks to extend its loans until end-2015.

As one of the Jiangsu region’s largest employers, the firm has received copious support from the government, which is currently helping Rongsheng with its restructuring.

Rongsheng also said it had signed a debt agreement with a syndicate of domestic banks in Anhui province that would extend its debt payments to the end of 2015.

Rongsheng has been one of the most prolific casualties of the global shipping slump. The industry is still trying to shake off a glut of ships ordered before the crisis which has sunk freight rates and caused many shipbuilding orders to be delayed or cancelled. ($1 = 7.7552 Hong Kong dollar) ($1 = 6.1136 Chinese yuan) (Reporting by Brenda Goh; Editing by Miral Fahmy)

Xi’an Rongsheng Biotechnology Co., Ltd. located in Xi"an Hi-tech Development Zone, is specialized in manufacturing high quality and reliable raw material which are widely used in fields of food, health, pharmaceuticals, cosmetics and others.